Mike Kratky
Stock Analyst at Leerink Partners
(3.50)
# 870
Out of 4,960 analysts
34
Total ratings
52.38%
Success rate
31.15%
Average return
Main Sectors:
Stocks Rated by Mike Kratky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Market Perform | $116 → $97 | $95.99 | +1.05% | 7 | Aug 15, 2025 | |
| BSX Boston Scientific | Initiates: Outperform | $118 | $106.17 | +11.14% | 1 | Jun 16, 2025 | |
| MDT Medtronic | Initiates: Outperform | $110 | $92.71 | +18.65% | 1 | Jun 16, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $28 | $17.05 | +64.22% | 1 | Feb 24, 2025 | |
| TXG 10x Genomics | Downgrades: Market Perform | $25 → $12 | $14.30 | -16.08% | 2 | Feb 13, 2025 | |
| DXCM DexCom | Maintains: Outperform | $90 → $87 | $82.26 | +5.76% | 2 | Oct 25, 2024 | |
| PEN Penumbra | Initiates: Outperform | $263 | $264.74 | -0.66% | 1 | Sep 3, 2024 | |
| TNDM Tandem Diabetes Care | Upgrades: Outperform | $34 → $45 | $11.93 | +277.20% | 2 | Apr 25, 2024 | |
| NPCE NeuroPace | Initiates: Outperform | $22 | $8.99 | +144.72% | 1 | Jan 30, 2024 | |
| PODD Insulet | Initiates: Outperform | $184 | $330.77 | -44.37% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $42 | $37.03 | +13.42% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $342 | $476.16 | -28.18% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $75 | $81.83 | -8.35% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $37 | $41.23 | -10.26% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $9 | $16.26 | -44.65% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $325 → $50 | $3.34 | +1,397.01% | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $45 | $1.45 | +3,003.45% | 2 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $145 → $315 | $414.68 | -24.04% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $26 → $31 | $44.10 | -29.71% | 2 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $15.24 | -8.14% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $19.23 | +108.06% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $392 → $384 | $11.32 | +3,293.73% | 1 | Aug 11, 2022 |
Inspire Medical Systems
Aug 15, 2025
Maintains: Market Perform
Price Target: $116 → $97
Current: $95.99
Upside: +1.05%
Boston Scientific
Jun 16, 2025
Initiates: Outperform
Price Target: $118
Current: $106.17
Upside: +11.14%
Medtronic
Jun 16, 2025
Initiates: Outperform
Price Target: $110
Current: $92.71
Upside: +18.65%
Beta Bionics
Feb 24, 2025
Initiates: Outperform
Price Target: $28
Current: $17.05
Upside: +64.22%
10x Genomics
Feb 13, 2025
Downgrades: Market Perform
Price Target: $25 → $12
Current: $14.30
Upside: -16.08%
DexCom
Oct 25, 2024
Maintains: Outperform
Price Target: $90 → $87
Current: $82.26
Upside: +5.76%
Penumbra
Sep 3, 2024
Initiates: Outperform
Price Target: $263
Current: $264.74
Upside: -0.66%
Tandem Diabetes Care
Apr 25, 2024
Upgrades: Outperform
Price Target: $34 → $45
Current: $11.93
Upside: +277.20%
NeuroPace
Jan 30, 2024
Initiates: Outperform
Price Target: $22
Current: $8.99
Upside: +144.72%
Insulet
Oct 16, 2023
Initiates: Outperform
Price Target: $184
Current: $330.77
Upside: -44.37%
Oct 16, 2023
Initiates: Outperform
Price Target: $42
Current: $37.03
Upside: +13.42%
Oct 16, 2023
Initiates: Outperform
Price Target: $342
Current: $476.16
Upside: -28.18%
Oct 16, 2023
Initiates: Market Perform
Price Target: $75
Current: $81.83
Upside: -8.35%
Oct 16, 2023
Initiates: Outperform
Price Target: $37
Current: $41.23
Upside: -10.26%
Oct 16, 2023
Initiates: Outperform
Price Target: $9
Current: $16.26
Upside: -44.65%
Aug 15, 2023
Downgrades: Market Perform
Price Target: $325 → $50
Current: $3.34
Upside: +1,397.01%
Jan 24, 2023
Maintains: Outperform
Price Target: $33 → $45
Current: $1.45
Upside: +3,003.45%
Dec 20, 2022
Maintains: Outperform
Price Target: $145 → $315
Current: $414.68
Upside: -24.04%
Dec 15, 2022
Maintains: Market Perform
Price Target: $26 → $31
Current: $44.10
Upside: -29.71%
Nov 4, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $15.24
Upside: -8.14%
Aug 15, 2022
Maintains: Outperform
Price Target: $32 → $40
Current: $19.23
Upside: +108.06%
Aug 11, 2022
Maintains: Outperform
Price Target: $392 → $384
Current: $11.32
Upside: +3,293.73%